microRNA expression profiles associated with survival, disease progression, and response to gefitinib in completely resected non-small-cell lung cancer with EGFR mutation

Unique microRNA molecular profiles in lung cancer diagnosis and prognosis

Nozomu Yanaihara, Natasha J. Caplen, Elise D. Bowman et al. · Cancer Cell · 2006 · 3K citations · Full text

Medicine, Molecular Biology, Oncology +14

Structures of Lung Cancer-Derived EGFR Mutants and Inhibitor Complexes: Mechanism of Activation and Insights into Differential Inhibitor Sensitivity

Cai‐Hong Yun, Titus J. Boggon, Yiqun Li et al. · Cancer Cell · 2007 · 1.2K citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +15

STAT3 Activation of miR-21 and miR-181b-1 via PTEN and CYLD Are Part of the Epigenetic Switch Linking Inflammation to Cancer

Dimitrios Iliopoulos, Savina Jaeger, Heather A. Hirsch et al. · Molecular Cell · 2010 · 831 citations · Full text

Medicine, Molecular Biology, Oncology +16

Proteomic patterns of tumour subsets in non-small-cell lung cancer

Kiyoshi Yanagisawa, Yu Shyr, Baogang Xu et al. · The Lancet · 2003 · 598 citations

Medicine, Cancer Biology, Oncology +16

MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers

Masahiro Seike, Akiteru Goto, Tetsuya Okano et al. · Proceedings of the National Academy of Sciences · 2009 · 501 citations · Full text

Medicine, Cancer Biology, Oncology +17